Inovio Pharmaceuticals
INO
#9752
Rank
HK$0.68 B
Marketcap
HK$8.31
Share price
-3.64%
Change (1 day)
-26.98%
Change (1 year)

Inovio Pharmaceuticals (INO) - Cash on Hand

Cash on Hand as of March 2026 : HK$0.29 Billion

According to Inovio Pharmaceuticals's latest financial reports the company has HK$0.29 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Inovio Pharmaceuticals - Cash on Hand chart (from 1998 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$0.45 B-37.69%
2024-12-31HK$0.73 B-35.61%
2023-12-31HK$1.13 B-42.59%
2022-12-31HK$1.97 B-36.83%
2021-12-31HK$3.12 B-1.94%
2020-12-31HK$3.19 B357.64%
2019-12-31HK$0.69 B9.62%
2018-12-31HK$0.63 B-36.1%
2017-12-31HK$0.99 B22.54%
2016-12-31HK$0.81 B-35.69%
2015-12-31HK$1.26 B73.97%
2014-12-31HK$0.72 B77.95%
2013-12-31HK$0.40 B284.84%
2012-12-31HK$0.10 B-54.81%
2011-12-31HK$0.23 B38.04%
2010-12-31HK$0.17 B-49.99%
2009-12-31HK$0.33 B211.63%
2008-12-31HK$0.10 B-48.66%
2007-12-31HK$0.21 B18.67%
2006-12-31HK$0.17 B34.53%
2005-12-31HK$0.13 B-4.26%
2004-12-31HK$0.13 B33.25%
2003-12-31HK$0.10 B1428.23%
2002-12-31HK$6.82 M-51.71%
2001-12-31HK$14.13 M
2001-03-31HK$50.9 M-32.87%
2000-03-31HK$75.83 M57.79%
1999-03-31HK$48.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$172.89 B 58,419.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$54.70 B 18,415.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$102.51 B 34,598.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$59.92 B 20,183.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$44.70 B 15,032.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$35.75 B 12,000.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$13.98 B 4,634.68%๐Ÿ‡บ๐Ÿ‡ธ USA